Soleus Capital Management’s GeneDx Holdings WGS Stock Holding History

Soleus Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$3.69M	–	111
2025 Q2	$3.69M	Buy	+40,000	New	+$3.14M	0.24%	65
2025 Q1	–	Sell	-4,000	Closed	-$307K	–	96
2024 Q4	$307K	Buy	+4,000	New	+$279K	0.02%	77
2024 Q3	–	Sell	-87,000	Closed	-$2.27M	–	107
2024 Q2	$2.27M	Sell	87,000 -696,376	-89%	-$13.2M	0.2%	78
2024 Q1	$7.15M	Buy	783,376 +723,376	+1,206%	+$4.34M	0.53%	53
2023 Q4	$165K	Sell	60,000 -721,396	-92%	-$1.68M	0.02%	71
2023 Q3	$2.84M	Buy	781,396 +70,000	+10%	+$384K	0.26%	64
2023 Q2	$4.24M	Buy	711,396 +167,760	+31%	+$1.33M	0.47%	54
2023 Q1	$6.55M	Buy	+543,636	New	+$7.25M	0.68%	42

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Soleus Capital Management's WGS Position: Q3 2025 in Review

Soleus Capital Management sold out of GeneDx Holdings (WGS) in Q3 2025, closing a stake of 40,000 shares — an estimated $3.69M sold.

Soleus Capital Management first reported a position in WGS in Q1 2023 and held it in 8 quarters. The position peaked at $7.15M in Q1 2024. 268 funds tracked by Wall St. Rank hold WGS as of Q3 2025.

Soleus Capital Management reported no remaining GeneDx Holdings position as of Q3 2025 after selling out during the quarter.
Soleus Capital Management sold 40,000 GeneDx Holdings shares in Q3 2025, an estimated $3.69M.
Soleus Capital Management first reported a position in GeneDx Holdings in Q1 2023 and held it in 8 quarters.
Soleus Capital Management's GeneDx Holdings position peaked at $7.15M in Q1 2024.
268 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2025.

Based on Soleus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.